Prognostic Value of VEGF in Human Pancreatic Ductal Adenocarcinoma
Yun Jeong Lim, Jong Kyun Lee, Cheol Keun Park, Sang Yong Song, Woo Young Jang, Hye Young Ha, Dong Il Park, Kyu Taek Lee, Seung Woon Paik, Byung Chul Yoo, Jong Chul Rhee
Korean J Intern Med. 2004;19(1):10-14.   Published online 2004 Mar 1     DOI: https://doi.org/10.3904/kjim.2004.19.1.10
Citations to this article as recorded by Crossref logo
VEGF and Id-1 in pancreatic adenocarcinoma: Prognostic significance and impact on angiogenesis
D. Georgiadou, T.N. Sergentanis, S. Sakellariou, G.M. Filippakis, F. Zagouri, D. Vlachodimitropoulos, T. Psaltopoulou, A.C. Lazaris, E. Patsouris, G.C. Zografos
European Journal of Surgical Oncology (EJSO).2014; 40(10): 1331.     CrossRef
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer
R A Smith, J Tang, C Tudur-Smith, J P Neoptolemos, P Ghaneh
British Journal of Cancer.2011; 104(9): 1440.     CrossRef
Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer
D. Ansari, A. Rosendahl, J. Elebro, R. Andersson
British Journal of Surgery.2011; 98(8): 1041.     CrossRef
HYPOXIA AND ANGIOGENESIS IN PANCREATIC CANCER
Giuseppe Garcea, Helena Doucas, Will P. Steward, Ashley R. Dennison, David P. Berry
ANZ Journal of Surgery.2006; 76(9): 830.     CrossRef
Prognostic value of p27kip1 expression in adenocarcinoma of the pancreatic head region
Jerzy Mielko, Wojciech P. Polkowski, Danuta G. Skomra, Andrzej J. Stanisławek, Andrzej M. Kurylcio, Elżbieta M. Korobowicz
HPB.2006; 8(3): 216.     CrossRef
Anti-Angiogenic Treatment of Gastrointestinal Malignancies
J. Stuart Salmon, A. Craig Lockhart, Jordan Berlin
Cancer Investigation.2005; 23(8): 712.     CrossRef
Anti-angiogenic strategies in gastrointestinal malignancies
Jonathan Whisenant, Emily Bergstand
Current Treatment Options in Oncology.2005; 6(5): 411.     CrossRef
Endogenous Stimulators and Inhibitors of Angiogenesis in Gastrointestinal Cancers: Basic Science to Clinical Application
Malin Sund, Michael Zeisberg, Raghu Kalluri
Gastroenterology.2005; 129(6): 2076.     CrossRef
Antibody-based cancer therapies: back to “polyclonals”?
Giovanni Paganelli, Rita De Santis
European Journal of Nuclear Medicine and Molecular.2004; 31(11): 1453.     CrossRef